NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years and Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS
Listen to Dr. Brown discuss with Dr. Saseen the Scientific Statement from the NLA and the AGS on managing hypercholesterolemia in adults aged 57 and…
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
Alan Brown, MD, FACC, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of “A Focused Update to the 2019 NLA Scientific Statement On…
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement
Dr. Alan Brown sits down with Dr. Carl Orringer and Dr. Michael Blaha to take a deeper look at the recent NLA scientific statement on…
The National Lipid Association scientific statement on coronary artery calcium (CAC) scoring to guide preventive strategies for ASCVD risk reduction
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
- 1
- 2